Aristotle University Of Thessaloniki (AUTH)
Η αντισυμφυτική δράση μιας νέας βιομεμβράνης κυτταρινικής βάσης με προσθήκη ατορβαστατίνης: πειραματική μελέτη σε επίμυες
Abstract
dc:descriptionIntroduction - Aims: Intraperitoneal adhesions are a common problem in abdominal surgery. Adhesion prevention is an important goal in surgical practice and many strategies have been applied, including fibrinolytic agents and synthetic solid barriers, yet none with durable results. The aim of this PhD thesis was to create and to compare subsequently the effectiveness of Statofilm, a novel antiadhesive biofilm based on crosslinked carboxymethylcellulose and the statin (3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor) atorvastatin, with that of well-known sodium hyaluronate-carboxymethylcellulose (Seprafilm®) in the prevention of postoperative intraperitoneal adhesions in rats. Materials and Methods: Statofilm was synthesized as an adhesion barrier, similar to Seprafilm® but sodium hyaluronate was substituted by atorvastatin in safe and clinical doses. One hundred male Wistar rats underwent a laparotomy and adhesions were induced by caecal abrasion. The animals were allocated to five groups: a control group with no adhesion barrier, Seprafilm® group, placebo group with a film containing carboxymethylcellulose without atorvastatin, and low- and high-dose groups with films containing carboxymethylcellulose and atorvastatin 0∙125 and 1 mg per kg bodyweight respectively. Adhesions were classified by two independent surgeons 2 weeks after surgery. Caecal biopsies were obtained for histological evaluation of fibrosis, inflammation and vascular proliferation. Results: All antiadhesive film groups (Seprafilm®, placebo, low-dose and high-dose) had statistically significant adhesion reduction compared with the control group (P < 0∙001, P = 0∙015, P < 0∙001 and P < 0∙001 respectively). The low-dose Statofilm was superior to Seprafilm® in terms of adhesion prevention (P = 0∙001). Adhesions were present in three-quarters of rats in the Seprafilm® group, but only one-quarter in the low-dose Statofilm group. The percentage adhesion reduction in groups IV-V, III, and II was 92-95%, 29-33% and 57-63%, respectively. The comparative adhesion reduction due to atorvastatin and sodium hyaluronate was 89-93% and 39-44%, respectively. Conclusions: The experimental data suggest that the newly developed adhesion barrier Statofilm has better results than Seprafilm® in preventing postoperative adhesions in rats. A low-dose atorvastatin-containing film, such as Statofilm, could be evaluated for future clinical application.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lalountas, Miltiadis
- Λαλούντας, Μιλτιάδης
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37328